BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8004834)

  • 1. Pattern of endothelin immunostaining during rejection episodes after kidney transplantation.
    Watschinger B; Vychytil A; Attar M; Wagner D; Schuller M; Hartter E; Ulrich W
    Clin Nephrol; 1994 Feb; 41(2):86-93. PubMed ID: 8004834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection.
    Chareandee C; Herman WH; Hricik DE; Simonson MS
    Am J Kidney Dis; 2000 Sep; 36(3):541-9. PubMed ID: 10977786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in biopsies obtained from human transplanted kidneys undergoing rejection.
    Hausknecht B; Voelkl S; Riess R; Gauer S; Goppelt-Struebe M
    Transplantation; 2003 Jul; 76(1):109-14. PubMed ID: 12865795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1, endothelin-3 and their receptors (endothelin(A) and endothelin(B)) in chronic renal transplant rejection in rats.
    Deng DX; Jiang J; Garcia B; Zhong R; Chakrabarti S
    Transpl Int; 2000; 13(3):175-82. PubMed ID: 10935699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated numbers of circulating endothelial cells in renal transplant recipients.
    Woywodt A; Schroeder M; Gwinner W; Mengel M; Jaeger M; Schwarz A; Haller H; Haubitz M
    Transplantation; 2003 Jul; 76(1):1-4. PubMed ID: 12865778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal immunohistochemical distribution, plasma levels and urinary excretion of endothelin after kidney transplantation.
    Murer L; Zacchello G; Dall'Amico R; Masiero M; Montini G; Basso G; Zacchello F
    J Nephrol; 1997; 10(6):318-24. PubMed ID: 9442445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
    Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
    Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between endothelin expression in early post-transplant biopsy specimens and long-term allograft function in living-related renal transplantation.
    Takeda M; Ishida T; Ishimura T; Fujisawa M
    Clin Transplant; 2006; 20(1):26-9. PubMed ID: 16556149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplant rejection under the microscope.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):662-6. PubMed ID: 17445568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
    Danilewicz M; Wagrowska-Danilewicz M
    Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE; Savikko J; Rintala JM; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA fragmentation in acute and chronic rejection after renal transplantation.
    Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
    Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of graft biopsy in renal transplantation under cyclosporin-A.
    Kiss D; Landmann J; Mihatsch M; Huser B; Brunner FP; Thiel G
    Clin Nephrol; 1992 Sep; 38(3):132-4. PubMed ID: 1395164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.